These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11289576)
1. Recombinant adeno-associated virus (rAAV) vector-mediated cotransduction of CD70 and CD80 into human malignant melanoma cells results in an additive T-cell response. Braun-Falco M; Hallek M Arch Dermatol Res; 2001 Feb; 293(1-2):12-7. PubMed ID: 11289576 [TBL] [Abstract][Full Text] [Related]
2. Involvement of CD70 and CD80 intracytoplasmic domains in the co-stimulatory signal required to provide an antitumor immune response. Douin-Echinard V; Péron JM; Lauwers-Cancès V; Favre G; Couderc B Int Immunol; 2003 Mar; 15(3):359-72. PubMed ID: 12618480 [TBL] [Abstract][Full Text] [Related]
3. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533 [TBL] [Abstract][Full Text] [Related]
4. CD40 and CD70 co-stimulate a potent in vivo antitumor T cell response. Nieland JD; Graus YF; Dortmans YE; Kremers BL; Kruisbeek AM J Immunother; 1998 May; 21(3):225-36. PubMed ID: 9610915 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. Couderc B; Zitvogel L; Douin-Echinard V; Djennane L; Tahara H; Favre G; Lotze MT; Robbins PD Cancer Gene Ther; 1998; 5(3):163-75. PubMed ID: 9622100 [TBL] [Abstract][Full Text] [Related]
6. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy. Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response. Wendtner CM; Nolte A; Mangold E; Buhmann R; Maass G; Chiorini JA; Winnacker EL; Emmerich B; Kotin RM; Hallek M Gene Ther; 1997 Jul; 4(7):726-35. PubMed ID: 9282174 [TBL] [Abstract][Full Text] [Related]
8. Differential function of CD80- and CD86-transfected human melanoma cells in the presence of IL-12 and IFN-gamma. Rudy W; Gückel B; Siebels M; Lindauer M; Meuer SC; Moebius U Int Immunol; 1997 Jun; 9(6):853-60. PubMed ID: 9199968 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells. Schmitter D; Bolliger U; Hallek M; Pichert G Br J Haematol; 1999 Jul; 106(1):64-70. PubMed ID: 10444164 [TBL] [Abstract][Full Text] [Related]
10. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70. Nieland JD; Kruisbeek AM Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081 [TBL] [Abstract][Full Text] [Related]
11. Replication-deficient adenovirus-mediated transfer of B7-1 (CD80) cDNA induces anti-tumour immunity in isolated human lung cancer. Iwakami SI; Setoguchi Y; Saijo Y; Azuma M; Fukuchi Y Respirology; 2001 Jun; 6(2):135-44. PubMed ID: 11422893 [TBL] [Abstract][Full Text] [Related]
12. Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens. Zeng W; Su M; Anderson KS; Sasada T Immunobiology; 2014 Aug; 219(8):583-92. PubMed ID: 24713579 [TBL] [Abstract][Full Text] [Related]
13. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. de Boer OJ; Hirsch F; van der Wal AC; van der Loos CM; Das PK; Becker AE Atherosclerosis; 1997 Sep; 133(2):227-34. PubMed ID: 9298683 [TBL] [Abstract][Full Text] [Related]
14. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. Hintzen RQ; Lens SM; Lammers K; Kuiper H; Beckmann MP; van Lier RA J Immunol; 1995 Mar; 154(6):2612-23. PubMed ID: 7876536 [TBL] [Abstract][Full Text] [Related]
15. Development of immunogenic colorectal cancer cell lines for vaccination: expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitro. Habicht A; Lindauer M; Galmbacher P; Rudy W; Gebert J; Schackert HK; Meuer SC; Moebius U Eur J Cancer; 1995 Dec; 31A(13-14):2396-402. PubMed ID: 8652275 [TBL] [Abstract][Full Text] [Related]
16. Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity. Cormary C; Hiver E; Mariamé B; Favre G; Tilkin-Mariamé AF Cancer Gene Ther; 2005 Dec; 12(12):963-72. PubMed ID: 15956983 [TBL] [Abstract][Full Text] [Related]
17. Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity. Orengo AM; Cantoni C; Neglia F; Biassoni R; Ferrini S Clin Exp Immunol; 1997 Mar; 107(3):608-13. PubMed ID: 9067541 [TBL] [Abstract][Full Text] [Related]
18. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189 [TBL] [Abstract][Full Text] [Related]
19. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148 [TBL] [Abstract][Full Text] [Related]
20. The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia. Matsumoto K; Anasetti C Leuk Lymphoma; 1999 Nov; 35(5-6):427-35. PubMed ID: 10609780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]